AgBiome and Syngenta Partner
News Dec 04, 2014
AgBiome LLC has announced an important research partnership with Syngenta Biotechnology, Inc. In the partnership, AgBiome and Syngenta bring unique strengths to discovery and development of novel, high-value trait products for protection of specific crops. Under the terms of this partnership, Syngenta funds a multi-year discovery research program at AgBiome and will select potential development candidates in its field and crop of interest based on successful technical milestones.
“We are excited to be working with Syngenta, one of the world’s leading agricultural companies, to discover new traits using AgBiome’s proprietary technologies,” said Dan Tomso, Chief Science Officer at AgBiome. “AgBiome’s ever-growing collection of microbes and sequence data, coupled with our proprietary screening capabilities, provide a powerful engine for trait discovery.”
“AgBiome is the ideal partner for this research program, and we anticipate great outcomes from the partnership,” said Patrice Selles, Head of External Collaborations and Adjacent Technologies at Syngenta. We have already enjoyed working closely with their team to structure this unique deal, which represents a true collaborative foundation, addressing the interests of both companies.”
Financial terms are not being disclosed.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.